| UniProt ID | FCHO1_HUMAN | |
|---|---|---|
| UniProt AC | O14526 | |
| Protein Name | F-BAR domain only protein 1 | |
| Gene Name | FCHO1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 889 | |
| Subcellular Localization |
Membrane, clathrin-coated pit Peripheral membrane protein Cytoplasmic side . Associated with forming but not mature clathrin-coated vesicles. The recruitment to coated-pits precede the one of clathrin and the adaptor protein complex AP-2. Accordi |
|
| Protein Description | Functions in an early step of clathrin-mediated endocytosis. Has both a membrane binding/bending activity and the ability to recruit proteins essential to the formation of functional clathrin-coated pits. May regulate Bmp signaling by regulating clathrin-mediated endocytosis of Bmp receptors.. | |
| Protein Sequence | MSYFGEHFWGEKNHGFEVLYHSVKQGPISTKELADFIRERATIEETYSKAMAKLSKLASNGTPMGTFAPLWEVFRVSSDKLALCHLELTRKLQDLIKDVLRYGEEQLKTHKKCKEEVVSTLDAVQVLSGVSQLLPKSRENYLNRCMDQERLRRESTSQKEMDKAETKTKKAAESLRRSVEKYNSARADFEQKMLDSALRFQAMEETHLRHMKALLGSYAHSVEDTHVQIGQVHEEFKQNIENVSVEMLLRKFAESKGTGREKPGPLDFEAYSAAALQEAMKRLRGAKAFRLPGLSRREREPEPPAAVDFLEPDSGTCPEVDEEGFTVRPDVTQNSTAEPSRFSSSDSDFDDEEPRKFYVHIKPAPARAPACSPEAAAAQLRATAGSLILPPGPGGTMKRHSSRDAAGKPQRPRSAPRTSSCAERLQSEEQVSKNLFGPPLESAFDHEDFTGSSSLGFTSSPSPFSSSSPENVEDSGLDSPSHAAPGPSPDSWVPRPGTPQSPPSCRAPPPEARGIRAPPLPDSPQPLASSPGPWGLEALAGGDLMPAPADPTAREGLAAPPRRLRSRKVSCPLTRSNGDLSRSLSPSPLGSSAASTALERPSFLSQTGHGVSRGPSPVVLGSQDALPIATAFTEYVHAYFRGHSPSCLARVTGELTMTFPAGIVRVFSGTPPPPVLSFRLVHTTAIEHFQPNADLLFSDPSQSDPETKDFWLNMAALTEALQRQAEQNPTASYYNVVLLRYQFSRPGPQSVPLQLSAHWQCGATLTQVSVEYGYRPGATAVPTPLTNVQILLPVGEPVTNVRLQPAATWNLEEKRLTWRLPDVSEAGGSGRLSASWEPLSGPSTPSPVAAQFTSEGTTLSGVDLELVGSGYRMSLVKRRFATGMYLVSC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | Phosphorylation | NHGFEVLYHSVKQGP CCCEEEEEEEHHCCC | 9.38 | 23917254 | |
| 30 | Phosphorylation | VKQGPISTKELADFI HHCCCCCHHHHHHHH | 29.29 | - | |
| 31 | Ubiquitination | KQGPISTKELADFIR HCCCCCHHHHHHHHH | 43.89 | - | |
| 80 | Acetylation | VFRVSSDKLALCHLE HHEECCCHHHHHHHH | 37.29 | 7975485 | |
| 97 | Ubiquitination | RKLQDLIKDVLRYGE HHHHHHHHHHHHHCH | 49.43 | - | |
| 141 | Phosphorylation | LPKSRENYLNRCMDQ CCCCHHHHHHHHHHH | 10.70 | 19664994 | |
| 155 | Phosphorylation | QERLRRESTSQKEMD HHHHHHHCCCHHHHH | 31.39 | - | |
| 174 | Phosphorylation | KTKKAAESLRRSVEK HHHHHHHHHHHHHHH | 23.58 | 25999147 | |
| 192 | Ubiquitination | ARADFEQKMLDSALR HHHHHHHHHHHHHHH | 33.94 | - | |
| 262 | Ubiquitination | SKGTGREKPGPLDFE HCCCCCCCCCCCCHH | 54.64 | - | |
| 295 | Phosphorylation | AFRLPGLSRREREPE HHCCCCCCCCCCCCC | 34.90 | 23917254 | |
| 343 | Phosphorylation | TAEPSRFSSSDSDFD CCCCCCCCCCCCCCC | 28.02 | 25262027 | |
| 344 | Phosphorylation | AEPSRFSSSDSDFDD CCCCCCCCCCCCCCC | 35.14 | 30108239 | |
| 345 | Phosphorylation | EPSRFSSSDSDFDDE CCCCCCCCCCCCCCC | 39.68 | 25262027 | |
| 347 | Phosphorylation | SRFSSSDSDFDDEEP CCCCCCCCCCCCCCC | 41.97 | 30108239 | |
| 358 | Phosphorylation | DEEPRKFYVHIKPAP CCCCCEEEEEEECCC | 8.31 | 29978859 | |
| 372 | Phosphorylation | PARAPACSPEAAAAQ CCCCCCCCHHHHHHH | 28.07 | 23401153 | |
| 386 | Phosphorylation | QLRATAGSLILPPGP HHHHHCCCEECCCCC | 15.12 | - | |
| 396 | Phosphorylation | LPPGPGGTMKRHSSR CCCCCCCCCCCCCCC | 25.99 | 27251275 | |
| 397 | Sulfoxidation | PPGPGGTMKRHSSRD CCCCCCCCCCCCCCC | 3.98 | 21406390 | |
| 420 | Phosphorylation | RSAPRTSSCAERLQS CCCCCCCHHHHHHHC | 19.41 | - | |
| 427 | Phosphorylation | SCAERLQSEEQVSKN HHHHHHHCHHHHHHH | 47.93 | 26552605 | |
| 432 | Phosphorylation | LQSEEQVSKNLFGPP HHCHHHHHHHCCCCC | 18.60 | 27251275 | |
| 475 | Phosphorylation | SPENVEDSGLDSPSH CCCCCCCCCCCCCCC | 27.96 | 26074081 | |
| 479 | Phosphorylation | VEDSGLDSPSHAAPG CCCCCCCCCCCCCCC | 33.09 | 26074081 | |
| 481 | Phosphorylation | DSGLDSPSHAAPGPS CCCCCCCCCCCCCCC | 29.70 | 26074081 | |
| 491 | Phosphorylation | APGPSPDSWVPRPGT CCCCCCCCCCCCCCC | 33.10 | 26074081 | |
| 498 | Phosphorylation | SWVPRPGTPQSPPSC CCCCCCCCCCCCCCC | 22.34 | 26074081 | |
| 501 | Phosphorylation | PRPGTPQSPPSCRAP CCCCCCCCCCCCCCC | 39.73 | 26074081 | |
| 504 | Phosphorylation | GTPQSPPSCRAPPPE CCCCCCCCCCCCCCC | 21.44 | 26074081 | |
| 523 | Phosphorylation | RAPPLPDSPQPLASS CCCCCCCCCCCCCCC | 24.40 | 28464451 | |
| 529 | Phosphorylation | DSPQPLASSPGPWGL CCCCCCCCCCCCCCC | 44.76 | 28450419 | |
| 530 | Phosphorylation | SPQPLASSPGPWGLE CCCCCCCCCCCCCCH | 28.41 | 28464451 | |
| 552 | Phosphorylation | MPAPADPTAREGLAA CCCCCCCCHHCCCCC | 38.60 | 28122231 | |
| 570 | Phosphorylation | RLRSRKVSCPLTRSN HHHCCCCCCCCCCCC | 17.04 | 23401153 | |
| 574 | Phosphorylation | RKVSCPLTRSNGDLS CCCCCCCCCCCCCCC | 19.73 | 28450419 | |
| 576 | Phosphorylation | VSCPLTRSNGDLSRS CCCCCCCCCCCCCCC | 39.67 | 24850871 | |
| 581 | Phosphorylation | TRSNGDLSRSLSPSP CCCCCCCCCCCCCCC | 25.27 | 28985074 | |
| 583 | Phosphorylation | SNGDLSRSLSPSPLG CCCCCCCCCCCCCCC | 29.80 | 22617229 | |
| 585 | Phosphorylation | GDLSRSLSPSPLGSS CCCCCCCCCCCCCCC | 25.28 | 22115753 | |
| 587 | Phosphorylation | LSRSLSPSPLGSSAA CCCCCCCCCCCCCHH | 29.40 | 22115753 | |
| 591 | Phosphorylation | LSPSPLGSSAASTAL CCCCCCCCCHHHHHH | 25.20 | 25262027 | |
| 592 | Phosphorylation | SPSPLGSSAASTALE CCCCCCCCHHHHHHH | 26.51 | 26074081 | |
| 595 | Phosphorylation | PLGSSAASTALERPS CCCCCHHHHHHHCCH | 17.58 | 26074081 | |
| 596 | Phosphorylation | LGSSAASTALERPSF CCCCHHHHHHHCCHH | 30.45 | 26074081 | |
| 602 | Phosphorylation | STALERPSFLSQTGH HHHHHCCHHHHCCCC | 45.07 | 26074081 | |
| 605 | Phosphorylation | LERPSFLSQTGHGVS HHCCHHHHCCCCCCC | 24.56 | 26074081 | |
| 607 | Phosphorylation | RPSFLSQTGHGVSRG CCHHHHCCCCCCCCC | 27.98 | 26074081 | |
| 612 | Phosphorylation | SQTGHGVSRGPSPVV HCCCCCCCCCCCCEE | 35.79 | 29978859 | |
| 616 | Phosphorylation | HGVSRGPSPVVLGSQ CCCCCCCCCEEECCC | 32.90 | 22115753 | |
| 622 | Phosphorylation | PSPVVLGSQDALPIA CCCEEECCCCHHHHH | 22.26 | 28464451 | |
| 630 | Phosphorylation | QDALPIATAFTEYVH CCHHHHHHHHHHHHH | 24.03 | 26074081 | |
| 644 | Phosphorylation | HAYFRGHSPSCLARV HHHHCCCCHHHHHHC | 22.72 | 28122231 | |
| 652 | Phosphorylation | PSCLARVTGELTMTF HHHHHHCCCEEEEEE | 21.27 | - | |
| 677 | Phosphorylation | TPPPPVLSFRLVHTT CCCCCEEEEEEEEEH | 14.46 | 24719451 | |
| 744 | Phosphorylation | VLLRYQFSRPGPQSV EEEEEEECCCCCCCC | 23.26 | 24719451 | |
| 808 | Phosphorylation | VRLQPAATWNLEEKR EEECCCCCCCCCCCE | 19.59 | - | |
| 814 | Ubiquitination | ATWNLEEKRLTWRLP CCCCCCCCEEEEECC | 43.25 | - | |
| 817 | Phosphorylation | NLEEKRLTWRLPDVS CCCCCEEEEECCCHH | 16.75 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FCHO1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FCHO1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FCHO1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ZBT16_HUMAN | ZBTB16 | physical | 16169070 | |
| A4_HUMAN | APP | physical | 21832049 | |
| PPL13_HUMAN | LGALS14 | physical | 25416956 | |
| EXOS5_HUMAN | EXOSC5 | physical | 25416956 | |
| FCHO2_HUMAN | FCHO2 | physical | 28514442 | |
| PCGF1_HUMAN | PCGF1 | physical | 28514442 | |
| EPS15_HUMAN | EPS15 | physical | 28514442 | |
| EP15R_HUMAN | EPS15L1 | physical | 28514442 | |
| AP2A1_HUMAN | AP2A1 | physical | 28514442 | |
| AP2A2_HUMAN | AP2A2 | physical | 28514442 | |
| SRR_HUMAN | SRR | physical | 28514442 | |
| AP1B1_HUMAN | AP1B1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, AND MASSSPECTROMETRY. | |